Innovating Works

POLYGENE

Desconocido
CAM-PAC: Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer POLYGENE AG participó en un FP7: Cancers are genetic disease arising from the accumulation of multiple molecular alterations in affected cells. Large-scale genomic, transcri...
Financiado
CARTARDIS: Identification and validation of novel pharmaceutical drug targets for cardiovascular disease POLYGENE AG participó en un FP7: "Cardiovascular disease (CVD) is one of the major diseases in Europe and the Western world, killing over 2 million people per year in Europe...
Financiado
EUTRIGTREAT: Identification and therapeutic targeting of common arrhythmia trigger mechanisms POLYGENE AG participó en un FP7: Arrhythmias are common manifestations of heart disease which frequently cause sudden cardiac death (SCD) or other devastating health problem...
Financiado
SYBIL: Systems biology for the functional validation of genetic determinants of skeletal diseases POLYGENE AG participó en un FP7: "The aim of SYBIL is to carry out extensive functional validation of the genetic determinants of rare and common skeletal diseases and the a...
Financiado
VIA: Vaccination In Atherosclerosis POLYGENE AG participó en un FP7: "Cardiovascular disease (CVD) is still a leading cause of death in the European Union (EU) accounting for nearly half of all deaths in Europ...
Financiado
TUMADOR: Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosupp... POLYGENE AG participó en un FP7: Studies have demonstrated the importance of CD73 in the spread of cancer. Overexpressed in numerous cancer types, this enzyme leads to the p...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.